#TOPCAT

Muthu Vaduganathan

mvaduganathan

Timely discussion. Do recurrent events always provide greater power than time-to-first events?In many cases, adapting to recurrent events is favorable as w #SOLOISTWHF #AHA20 @DLBHATTMDHowever, despite ↓ events, time-to-first may

Carlos G Santos-Gallego, MD

SantosGallegoMD

Wow! Big news for HFpEF! Shall sacubitril/valsartan and spironolactone be FDA-approved for HFpEF? FDA Advisory Panel has just voted today 12-1 to approve an expanded indication for sacubitril/valsartan based on

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.